Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Adenocarcinoma

Explore clinical trials studying Pancreatic Adenocarcinoma. Study availability and eligibility vary by location and protocol.

205 public trials 59 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Adenocarcinoma trial results

Recruiting

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07562152

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +17 more
Locations
  • City of Hope Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Medical Oncology Hematology Consultants Newark, Delaware, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
View all 51 locations
View Trial Details
Recruiting

Evaluation of XYA02 in Patients With Advanced Solid Tumors

NCT07670312

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +38 more
Locations
  • Chris O'Brien Life House Sydney, New South Wales, Australia
  • Westmead Hospital Sydney, New South Wales, Australia
  • Monash Medical Centre Melbourne, Victoria, Australia
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
View Trial Details
Recruiting

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

NCT07488676

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +15 more
Locations
  • UAB Medicine - UAB Hospital Birmingham, Alabama, United States
  • START Los Angeles Los Angeles, California, United States
  • Indiana University (IU) Health - Multi-D Oncology Clinic Indianapolis, Indiana, United States
  • START Midwest Grand Rapids, Michigan, United States
View all 21 locations
View Trial Details
Recruiting

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

NCT07349537

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, CRC, +30 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • START Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

Evaluating Novel Therapies in ctDNA Positive GI Cancers

NCT05482516

Conditions
Adenocarcinoma, Adenocarcinoma of Biliary Tract, Carcinoma, +24 more
Locations
  • Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Medstar Washington Hospital Center Washington D.C., District of Columbia, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Recruiting

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07491445

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 49 locations
View Trial Details
Recruiting

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

NCT05059444

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Carcinoma, +82 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • University of California, San Diego La Jolla, California, United States
View all 57 locations
View Trial Details
Recruiting

A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

NCT05365581

Conditions
Adenocarcinoma, Carcinoma, Gastric Adenocarcinoma, +5 more
Locations
  • University of California Irvine Medical Center Orange, California, United States
  • UCLA Dept of Medicine - Hematology/Oncology, Santa Monica Santa Monica, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
View all 46 locations
View Trial Details
Recruiting

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

NCT07621718

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Piedmont Healthcare Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details

Related conditions